Intelligent Bio Solutions Inc.
INBS· Nasdaq
INBSIntelligent Bio Solutions Inc.
Filed May 13, 2021 · 10-Q · 43 days after period end · 0001493152-21-011202
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Revenue | $34.29K | -$1.53K |
| Net Income | -$3.13M | -$112.59K |
| EPS Diluted | -$0.27 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 13, 2021 · 43 d after period end
